Furthermore, it has been demonstrated that PGC-1α plays an important role in a variety of metabolic processes, including mitochondrial biogenesis and mitochondrial β-oxidation, and PGC-1α has emerged as an important therapeutic target for fatty liver disease [36]. The gene discussed is PPARGC1A; the disease is fatty liver disease.